EUROBACT II

Eurobact 2: A worldwide cohort study on the Epidemiology and determinants of outcomes of Hospital Acquired Blood Stream Infections in the Intensive Care.

The Eurobact 2 study will provide new insights on the management of critically ill patients with severe infections and difficult to treat pathogens. 8 years after the first Eurobact study there is a worldwide increase in antimicrobial resistance. Meanwhile there have been advances in the management of patients with sepsis, in microbiology laboratory techniques and new antibiotic combinations have been made available for difficult to treat pathogens

Each ICU will include 10 consecutive patients with HA-BSI or for 3 months maximum.

This is an observational study. No interventions or supplementary tests are required, everything should be anonymously collected from the patient's chart.

With support from around the globe, National coordinators in 16 different countries and counting, endorsement by the by the Infection section of the ESICM and the ESCMID Study Group for Infections in Critically Ill Patients (ESGCIP) we will provide with a well required update on Hospital Acquired Blood Stream Infections (HA-BSI) in the Intensive Care.

If you want to obtain more information or register your interest, please email us at eurobact@eurobact.org

The Eurobact 1 study included 1156 patients from 162 ICUs in 24 countries. Click here to see the results and publications from the Eurobact 1 study.


Click here to register to participate in the Eurobact 2 study


Our committee

Primary investigators

Alexis Tabah, MD - Brisbane, Australia.
Jean-François Timsit, MD, PhD - Paris, France.

National coordinators

Argentina - Gabriela Vidal (NC)
Australia - Alexis Tabah (NC)
Australia - Mahesh Ramanan
Australia - Jeffrey Lipman
Australia - Kathryn Wilks
Australia - Kevin Laupland
Belgium - Liesbet De Bus (NC)
Belgium - Jan de Waele
Brazil - Ho Yeh Li (NC)
Bosnia & Herzegovina - Pedja Kovacevic (NC)
Bolivia - Monica Crespo (NC)
Canada - Anand Kumar
Canada - Wendy Sligl (NC)
China - Haibo Qiu (NC)
Colombia - Mario Arias (NC)
Croatia - Ina Filipovic-Grcic (NC)
Dubai - Adel Alsisi (NC)
Egypt - Adel Alsisi (NC)
France - Marc Leone (NC)
France - Jean-Fran├žois Timsit
France - Etienne Ruppe
Georgia - Vakhtang Kaloiani (NC)
Germany - Hendrik Bracht (NC)
Greece - Kostoula Arvaniti (NC)
Greece - Georgios Dimopoulos
Hong Kong - Lowell Ling (NC)
Hungary - Akos Csomos (NC)
India - Mohan Gurjar (NC)
Iran - Farid Zand (NC)
Israel - Pierre Singer (NC)
Italy - Matteo Bassetti (NC)
Japan - Yoshiro Hayashi (NC)
Lebanon - Fayez Abillama (NC)
Libya - Muhammed Elhadi (NC)
Lithuania - Saulius Vosylius (NC)
Malaysia - Helmi Sulaiman (NC)
Mexico - Silvio A. Namendys-Silva (NC)
Morocco - Khalid Abidi (NC)
Netherlands - Jeroen Schouten (NC)
Nepal - Gentle Shrestha (NC)
New Zealand - Ross Freebairn (NC)
Nigeria - Oyebola O. Adekola (NC)
Philippines - Aaron Mark Hernandez (NC)
Poland - Adam Mikstacki (NC)
Portugal - Jose Artur Paiva (NC)
Portugal - Pedro Povoa
Qatar - Ali Aithssain (NC)
Republic of Ireland - Ignacio Martin-Loeches (NC)
Republic of Korea - Jeon Kyeongman (NC)
Russian Federation - Alexey Gritsan (NC)
Singapore - Andrea Kwa (NC)
Singapore - Qing Yuan Goh (NC)
South Africa - Mervyn Mer (NC)
Spain - Ricard Ferrer Rocca (NC)
Spain - Jose Garnacho-Montero
Sudan - Bashir El Sanousi (NC)
Sweden - Fredrik Sjovall (NC)
Taiwan - Tony Yeh (NC)
Tunisia - Mounir Bouaziz (NC)
Turkey - Murat Akova (NC)
United Kingdom - Andrew Conway Morris (NC)

Operational committee

Alexis Tabah
Stephane Ruckly

Data management and quality control

Alexis Tabah
Cheryl Fourie
Mahesh Ramanan
Stephane Ruckly

Statistical analysis

Jean-François Timsit
Stephane Ruckly